Traws Pharma, Inc. (TRAW)

Traws Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-18.16	-18.95	-18.96	-16.16	-25.16	-21.5
Depreciation & Amortization	0.02	0.02	0.01	0.01	0.01	0.01
Share-Based Compensation	1.3	1.3	1.17	0.58	0.37	1.05
Other Operating Activities	-0.97	-0.3	1.48	-3.91	1.7	-0.39
Operating Cash Flow	-17.81	-17.93	-16.29	-19.49	-23.08	-20.83
Capital Expenditures	0	-0.01	0	0	-0.02	-0.06
Investing Cash Flow	0	-0.01	0	0	-0.02	-0.06
Share Issuance / Repurchase	0	0	0	55.56	19.36	26.61
Other Financing Activities	-	-	-	-	0	0.04
Financing Cash Flow	0	0	0	55.56	19.36	26.65
Exchange Rate Effect	-0	0.01	-0.02	-0.03	0.03	-0.01
Net Cash Flow	-17.83	-17.94	-16.31	36.05	-3.7	5.76
Free Cash Flow	-17.81	-17.95	-16.29	-19.49	-23.09	-20.89
Free Cash Flow Margin	-7881.86%	-7940.71%	-7209.73%	-8622.57%	-9995.67%	-956.76%
Free Cash Flow Per Share	-0.85	-0.85	-0.78	-1.16	-1.99	-21.78

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).